{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T15:09:21Z","timestamp":1784819361361,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,19]],"date-time":"2016-05-19T00:00:00Z","timestamp":1463616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.clinthera.2016.05.003","type":"journal-article","created":{"date-parts":[[2016,5,31]],"date-time":"2016-05-31T22:04:40Z","timestamp":1464732280000},"page":"1638-1652.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["A Predictive Model to Estimate Cost Savings of a Novel Diagnostic Blood Panel for Diagnosis of Diarrhea-predominant Irritable Bowel Syndrome"],"prefix":"10.1016","volume":"38","author":[{"given":"Mark","family":"Pimentel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Purdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raf","family":"Magar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Rezaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2016.05.003_bib1","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/apt.12938","article-title":"Review article: the economic impact of the irritable bowel syndrome","volume":"40","author":"Canavan","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2016.05.003_bib2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1471-2296-14-92","article-title":"GP perspectives of irritable bowel syndrome\u2014an accepted illness, but management deviates from guidelines: a qualitative study","volume":"14","author":"Harkness","year":"2013","journal-title":"BMC Fam Pract"},{"key":"10.1016\/j.clinthera.2016.05.003_bib3","first-page":"71","article-title":"The epidemiology of irritable bowel syndrome","volume":"6","author":"Canavan","year":"2014","journal-title":"Clin Epidemiol"},{"issue":"suppl 1","key":"10.1016\/j.clinthera.2016.05.003_bib4","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/ajg.2014.187","article-title":"American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation","volume":"109","author":"Ford","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinthera.2016.05.003_bib5","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1440-1746.2009.06120.x","article-title":"Irritable bowel syndrome: epidemiology, diagnosis and treatment: an update for health-care practitioners","volume":"25","author":"Grundmann","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2016.05.003_bib6","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/j.1365-2036.2005.02463.x","article-title":"Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact","volume":"21","author":"Hungin","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2016.05.003_bib7","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cgh.2012.02.029","article-title":"Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis","volume":"10","author":"Lovell","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2016.05.003_bib8","first-page":"495","article-title":"Prevalence of irritable bowel syndrome: a community survey","volume":"54","author":"Wilson","year":"2004","journal-title":"Br J Gen Pract"},{"issue":"4 suppl 1","key":"10.1016\/j.clinthera.2016.05.003_bib9","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1053\/j.gastro.2005.02.012","article-title":"What are the sensitivity and specificity of serologic tests for celiac disease? Do sensitivity and specificity vary in different populations?","volume":"128","author":"Hill","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2016.05.003_bib10","first-page":"307","article-title":"Guidelines\u2014Rome III Diagnostic Criteria for Functional Gastrointestinal Disorders","volume":"15","year":"2006","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1016\/j.clinthera.2016.05.003_bib11","doi-asserted-by":"crossref","first-page":"e106478","DOI":"10.1371\/journal.pone.0106478","article-title":"The incidence of other gastroenterological disease following diagnosis of irritable bowel syndrome in the UK: a cohort study","volume":"9","author":"Canavan","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.clinthera.2016.05.003_bib12","doi-asserted-by":"crossref","first-page":"h1216","DOI":"10.1136\/bmj.h701","article-title":"Diagnosis and management of irritable bowel syndrome in adults in primary care: summary of NICE guidance","volume":"350","author":"Hookway","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2016.05.003_bib13","first-page":"585","article-title":"Diagnosis and care of irritable bowel syndrome in a community-based population","volume":"7","author":"Yawn","year":"2001","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.clinthera.2016.05.003_bib14","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ajg.2015.6","article-title":"A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS","volume":"110","author":"Menees","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinthera.2016.05.003_bib15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ibd.20275","article-title":"Discriminating IBD from IBS: comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies","volume":"14","author":"Schoepfer","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clinthera.2016.05.003_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/00019053-200624010-00002","article-title":"Costs of irritable bowel syndrome in the UK and US","volume":"24","author":"Maxion-Bergemann","year":"2006","journal-title":"Pharmacoeconomics"},{"issue":"11 suppl 5","key":"10.1016\/j.clinthera.2016.05.003_bib17","first-page":"1","article-title":"An evidence-based look at misconceptions in the treatment of patients with IBS-D","volume":"9","author":"Lacy","year":"2013","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"suppl 1","key":"10.1016\/j.clinthera.2016.05.003_bib18","first-page":"S","article-title":"Deep sequencing reveals that the microbiome of the human duodenum is unique and unrelated to stool bacterial profiling","volume":"144","author":"Chang","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2016.05.003_bib19","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1111\/j.1572-0241.2000.03368.x","article-title":"Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome","volume":"95","author":"Pimentel","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinthera.2016.05.003_bib20","first-page":"412","article-title":"Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. A double-blind, randomized, placebo-controlled study","volume":"98","author":"Pimentel","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinthera.2016.05.003_bib21","doi-asserted-by":"crossref","first-page":"e0126438","DOI":"10.1371\/journal.pone.0126438","article-title":"Development and validation of a biomarker for diarrhea-predominant irritable bowel syndrome in human subjects","volume":"10","author":"Pimentel","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.clinthera.2016.05.003_bib22","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ijantimicag.2013.12.008","article-title":"In vitro activity of rifaximin against isolates from patients with small intestinal bacterial overgrowth","volume":"43","author":"Pistiki","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.clinthera.2016.05.003_bib23","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1136\/gut.2006.108712","article-title":"Small intestinal bacterial overgrowth in patients with irritable bowel syndrome","volume":"56","author":"Posserud","year":"2007","journal-title":"Gut"},{"issue":"suppl 1","key":"10.1016\/j.clinthera.2016.05.003_bib24","first-page":"S","article-title":"The first large scale deep sequencing of the duodenal microbiome in irritable bowel syndrome reveals striking differences compared to healthy controls","volume":"144","author":"Pimentel","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2016.05.003_bib25","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s10620-014-3435-5","article-title":"Autoimmunity links vinculin to the pathophysiology of chronic functional bowel changes following Campylobacter jejuni infection in a rat model","volume":"60","author":"Pimentel","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clinthera.2016.05.003_bib26","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10552-011-9878-5","article-title":"Adverse events after screening and follow-up colonoscopy","volume":"23","author":"Rutter","year":"2012","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.clinthera.2016.05.003_bib27","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1111\/j.1572-0241.2002.07027.x","article-title":"The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review","volume":"97","author":"Cash","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinthera.2016.05.003_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.envsoft.2015.01.004","article-title":"A simple and efficient method for global sensitivity analysis based on cumulative distribution functions","volume":"67","author":"Pianosi","year":"2015","journal-title":"Environ Model Softw"},{"key":"10.1016\/j.clinthera.2016.05.003_bib29","unstructured":"Howden LM, Meyer JA. Age and sex composition: 2010 census briefs, 2011. http:\/\/wwwcensusgov\/prod\/cen2010\/briefs\/c2010br-03pdf. Accessed: August 24, 2015."},{"key":"10.1016\/j.clinthera.2016.05.003_bib30","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1004409","article-title":"Rifaximin therapy for patients with irritable bowel syndrome without constipation","volume":"364","author":"Pimentel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2016.05.003_bib31","unstructured":"IBS Physician Survey. Administered by AHRM Inc. April\u2013June 2015."},{"key":"10.1016\/j.clinthera.2016.05.003_bib32","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/fampra\/cmn087","article-title":"Patients\u05f3 explanatory models for irritable bowel syndrome: symptoms and treatment more important than explaining aetiology","volume":"26","author":"Casiday","year":"2009","journal-title":"Fam Pract"},{"key":"10.1016\/j.clinthera.2016.05.003_bib33","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.0269-2813.2004.01807.x","article-title":"Impact of functional gastrointestinal disorders on health-related quality of life: a population-based case-control study","volume":"19","author":"Halder","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"issue":"1 suppl","key":"10.1016\/j.clinthera.2016.05.003_bib34","first-page":"S7","article-title":"Total costs of IBS: employer and managed care perspective","volume":"11","author":"Cash","year":"2005","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.clinthera.2016.05.003_bib35","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.gie.2005.06.037","article-title":"Utilization of colonoscopy in the United States: results from a national consortium","volume":"62","author":"Lieberman","year":"2005","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.clinthera.2016.05.003_bib36","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1053\/j.gastro.2004.02.020","article-title":"Irritable bowel syndrome and surgery: a multivariable analysis","volume":"126","author":"Longstreth","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2016.05.003_bib37","doi-asserted-by":"crossref","first-page":"7424","DOI":"10.3748\/wjg.v20.i23.7424","article-title":"Capsule endoscopy in patients refusing conventional endoscopy","volume":"20","author":"Romero-Vazquez","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinthera.2016.05.003_bib38","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1155\/2010\/714591","article-title":"Predictors of serious complications associated with lower gastrointestinal endoscopy in a major city-wide health region","volume":"24","author":"Singh","year":"2010","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.clinthera.2016.05.003_bib39","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1046\/j.1365-2036.1999.00576.x","article-title":"One-year follow-up of newly diagnosed irritable bowel syndrome patients","volume":"13","author":"Ruigomez","year":"1999","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291816303095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291816303095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T10:26:37Z","timestamp":1536661597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291816303095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0149291816303095"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2016.05.003","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Predictive Model to Estimate Cost Savings of a Novel Diagnostic Blood Panel for Diagnosis of Diarrhea-predominant Irritable Bowel Syndrome","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2016.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}